Rubric Capital Management (New York)’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3M | Hold |
26,713,503
| – | – | 0.84% | 30 |
|
|
2025
Q1 | $58.8M | Hold |
26,713,503
| – | – | 1.05% | 28 |
|
|
2024
Q4 | $40.9M | Hold |
26,713,503
| – | – | 0.52% | 36 |
|
|
2024
Q3 | $53.2M | Hold |
26,713,503
| – | – | 0.87% | 32 |
|
|
2024
Q2 | $93.5M | Hold |
26,713,503
| – | – | 2.45% | 11 |
|
|
2024
Q1 | $74M | Hold |
26,713,503
| – | – | 2.19% | 14 |
|
|
2023
Q4 | $45.4M | Hold |
26,713,503
| – | – | 0.94% | 24 |
|
|
2023
Q3 | $27.5M | Buy |
26,713,503
+14,963,503
| +127% | +$15.4M | 1.03% | 29 |
|
|
2023
Q2 | $13.6M | Hold |
11,750,000
| – | – | 0.58% | 41 |
|
|
2023
Q1 | $17.7M | Hold |
11,750,000
| – | – | 0.46% | 45 |
|
|
2022
Q4 | $29.4M | Buy |
11,750,000
+9,233,672
| +367% | +$23.1M | 1.28% | 26 |
|
|
2022
Q3 | $10.6M | Buy |
+2,516,328
| New | +$10.6M | 0.53% | 45 |
|
|
2019
Q2 | – | Sell |
-1,500,000
| Closed | -$36.7M | – | 60 |
|
|
2019
Q1 | $36.7M | Sell |
1,500,000
-1,287,592
| -46% | -$31.5M | 3.42% | 9 |
|
|
2018
Q4 | $72.3M | Buy |
2,787,592
+828,742
| +42% | +$21.5M | 8.95% | 1 |
|
|
2018
Q3 | $62M | Buy |
1,958,850
+818,603
| +72% | +$25.9M | 6.55% | 3 |
|
|
2018
Q2 | $44.3M | Sell |
1,140,247
-369,761
| -24% | -$14.4M | 4.35% | 10 |
|
|
2018
Q1 | $41.7M | Sell |
1,510,008
-687,304
| -31% | -$19M | 3.88% | 10 |
|
|
2017
Q4 | $39.8M | Buy |
2,197,312
+297,312
| +16% | +$5.38M | 4.91% | 3 |
|
|
2017
Q3 | $30.7M | Buy |
1,900,000
+200,000
| +12% | +$3.23M | 2.78% | 3 |
|
|
2017
Q2 | $23.5M | Buy |
1,700,000
+100,000
| +6% | +$1.39M | 4.85% | 1 |
|
|
2017
Q1 | $24M | Buy |
1,600,000
+1,050,000
| +191% | +$15.8M | 6.99% | 2 |
|
|
2016
Q4 | $7.21M | Buy |
+550,000
| New | +$7.21M | 2.48% | 9 |
|